Standard BioTools price target lowered to $2.50 from $2.75 at TD Cowen

TD Cowen lowered the firm’s price target on Standard BioTools (LAB) to $2.50 from $2.75 and keeps a Buy rating on the shares. The firm said they reported a 9% sales beat with margins ahead and cost controls solid, though sales upside was largely timing-related.